Healthcare Triangle, Inc.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
HCTI$4.21-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss
| Three Months Ended June 30, · Six Months Ended June 30, | |||||
|---|---|---|---|---|---|
| Note | 2026 | 2025 | 2026 | 2025 | |
| Net revenue | $9,193 | $3,558 | $19,046 | $7,263 | |
| Cost of revenue (exclusive of depreciation and amortization shown separately below) | 7,126 | 3,064 | 14,587 | 6,440 | |
| Gross margin | 2,067 | 494 | 4,459 | 823 | |
| Operating expenses | |||||
| Sales and marketing | 720 | 616 | 2,500 | 990 | |
| General and administrative | 4,821 | 1,182 | 8,038 | 2,380 | |
| Research and development | 51 | 55 | 136 | 198 | |
| Bad debt expense | 17 | - | 142 | - | |
| Depreciation and amortization | 6,7 | 529 | - | 1,339 | 12 |
| Total operating expenses | 6,138 | 1,853 | 12,155 | 3,580 | |
| Loss from operations | (4,071) | (1,359) | (7,696) | (2,757) | |
| Other income | 438 | 13 | 446 | 124 | |
| Changes in fair value | 9 | (652) | - | (3,088) | - |
| Interest expense | (89) | (21) | (173) | (435) | |
| Forex loss | (17) | - | (80) | - | |
| Loss before income tax | (4,391) | (1,367) | (10,591) | (3,068) | |
| Income tax expense | (24) | - | (24) | - | |
| Net loss | $(4,415) | $(1,367) | $(10,615) | $(3,068) | |
| Other comprehensive income (OCI) | |||||
| Foreign currency translation gain/(loss) | 237 | - | 73 | - | |
| Comprehensive loss | $(4,178) | (1,367) | $(10,542) | (3,068) | |
| Comprehensive loss attributable to: | |||||
| Stockholders | $(4,150) | (1,367) | $(10,490) | (3,068) | |
| Non-controlling interest | (28) | - | (52) | - | |
| Net loss per common share—basic and diluted, attributable to: | |||||
| Stockholders | 16 | (1.56) | (35.01) | (7.13) | (153.65) |
| Weighted average shares outstanding used in per common share computations: | |||||
| Basic and diluted | 2,805,546 | 39,057 | 1,481,343 | 19,964 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.